Return to Today's science sparks archives

2020-10-01

Fig 1. Exercise-induced protection against tissue-specific perturbations in organs involved in cancer regulation or prone to malignancy.

Fig 1. Exercise-induced protection against tissue-specific perturbations in organs involved in cancer regulation or prone to malignancy.
  • Koelwyn GJ, Zhuang X, Tammela T, Schietinger A, Jones LW

  • Nat Metab. 2020 Sep;2(9):849-857.

2020-10-02

Fig 3. Kaplan-Meier analyses of response and survival outcomes in the efficacy-evaluable set, by best overall response:
Kaplan-Meier analysis of duration of response (A), progression-free survival (B), and overall survival (C). NR=not reached.

Fig 3. Kaplan-Meier analyses of response and survival outcomes in the efficacy-evaluable set, by best overall response: Kaplan-Meier analysis of duration of response (A), progression-free survival (B), and overall survival (C). NR=not reached.
  • Abramson JS, Palomba ML, Gordon LI, Lunning MA, Wang M, Arnason J, Mehta A, Purev E, Maloney DG, Andreadis C, Sehgal A, Solomon SR, Ghosh N, Albertson TM, Garcia J, Kostic A, Mallaney M, Ogasawara K, Newhall K, Kim Y, Li D, Siddiqi T

  • Lancet. 2020 Sep 19;396(10254):839-852.

2020-10-05

Graphical Abstract

Graphical Abstract
  • Arruabarrena-Aristorena A, Maag JLV, Kittane S, Cai Y, Karthaus WR, Ladewig E, Park J, Kannan S, Ferrando L, Cocco E, Ho SY, Tan DS, Sallaku M, Wu F, Acevedo B, Selenica P, Ross DS, Witkin M, Sawyers CL, Reis-Filho JS, Verma CS, Jauch R, Koche R, Baselga J, Razavi P, Toska E, Scaltriti M

  • Cancer Cell. 2020 Aug 25:S1535-6108(20)30414-1.

2020-10-06

Graphical abstract

Graphical abstract
  • Diaz-Salazar C, Sun JC

  • Cell Rep. 2020 Sep 22;32(12):108186. doi: 10.1016/j.celrep.2020.108186.
Open Access button

2020-10-07

Visual abstract

Visual abstract
  • Taylor J, Mi X, North K, Binder M, Penson A, Lasho T, Knorr K, Haddadin M, Liu B, Pangallo J, Benbarche S, Wiseman D, Tefferi A, Halene S, Liang Y, Patnaik MM, Bradley RK, Abdel-Wahab O

  • Blood. 2020 Sep 24;136(13):1477-1486. doi: 10.1182/blood.2020006868.

2020-10-08

Fig. 3. Effect of brefeldin A on expression of mMOR-1/Flag induced by mMOR-1G/HA and heterodimerization of mMOR-1/Flag and mMOR-1G/HA in OPRM1-KD Be(2)C cells.

Fig. 3. Effect of brefeldin A on expression of mMOR-1/Flag induced by mMOR-1G/HA and heterodimerization of mMOR-1/Flag and mMOR-1G/HA in OPRM1-KD Be(2)C cells.
  • Zhang T, Xu J, Pan YX

  • Mol Pharmacol. 2020 Oct;98(4):518-527. doi: 10.1124/mol.120.119453. Epub 2020 Jul 28.
Open Access button

2020-10-09

Figure S2. Genomic Distributions of Rigma and Pyrgo, Related to Figure 2.

Figure S2. Genomic Distributions of Rigma and Pyrgo, Related to Figure 2.
  • Hadi K, Yao X, Behr JM, Deshpande A, Xanthopoulakis C, Tian H, Kudman S, Rosiene J, Darmofal M, DeRose J, Mortensen R, Adney EM, Shaiber A, Gajic Z, Sigouros M, Eng K, Wala JA, Wrzeszczynski KO, Arora K, Shah M, Emde AK, Felice V, Frank MO, Darnell RB, Ghandi M, Huang F, Dewhurst S, Maciejowski J, de Lange T, Setton J, Riaz N, Reis-Filho JS, Powell S, Knowles DA, Reznik E, Mishra B, Beroukhim R, Zody MC, Robine N, Oman KM, Sanchez CA, Kuhner MK, Smith LP, Galipeau PC, Paulson TG, Reid BJ, Li X, Wilkes D, Sboner A, Mosquera JM, Elemento O, Imielinski M

  • Cell. 2020 Oct 1;183(1):197-210.e32. doi: 10.1016/j.cell.2020.08.006.

2020-10-12

Figure 6. Relocalization of Fne from Cytoplasm into the Nucleus of elav Mutant Neurons.

Figure 6. Relocalization of Fne from Cytoplasm into the Nucleus of elav Mutant Neurons.
  • Wei L, Lee S, Majumdar S, Zhang B, Sanfilippo P, Joseph B, Miura P, Soller M, Lai EC

  • Mol Cell. 2020 Oct 1;80(1):140-155.e6. doi: 10.1016/j.molcel.2020.09.007.

2020-10-13

Fig 1.  Cumulative Hazard of New Primary Cutaneous Melanoma After Starting Immune Checkpoint Inhibitor Treatment

Fig 1. Cumulative Hazard of New Primary Cutaneous Melanoma After Starting Immune Checkpoint Inhibitor Treatment
  • Nanda JK, Dusza SW, Navarrete-Dechent C, Liopyris K, Marghoob AA, Marchetti MA

  • JAMA Dermatol. 2020 Sep 16. pii: 2770777. doi: 10.1001/jamadermatol.2020.3671.

2020-10-14

Fig 1. Protein-protein association network of DS-affinity enriched proteins analyzed with STRING.

Fig 1. Protein-protein association network of DS-affinity enriched proteins analyzed with STRING.
  • Wang JY, Zhang W, Rho JH, Roehrl MW, Roehrl MH

  • Clin Proteomics. 2020 Sep 21;17:35. doi: 10.1186/s12014-020-09298-3. eCollection 2020.
Open Access button

2020-10-15

Fig. 1: Antibiotics promote temporary depletion of the microbiota and transient expansion of Lm in the intestine.

Fig. 1: Antibiotics promote temporary depletion of the microbiota and transient expansion of Lm in the intestine.
  • Becattini S, Littmann ER, Seok R, Amoretti L, Fontana E, Wright R, Gjonbalaj M, Leiner IM, Plitas G, Hohl TM, Pamer EG

  • Nat Commun. 2020 Sep 8;11(1):4475. doi: 10.1038/s41467-020-18248-4.
Open Access button

2020-10-16

Fig 2. Pathological complete response co-primary endpoints in the all-randomised and PD-L1-positive populations, and pathological complete response in the PD-L1-negative population.

Fig 2. Pathological complete response co-primary endpoints in the all-randomised and PD-L1-positive populations, and pathological complete response in the PD-L1-negative population.
  • Mittendorf EA, Zhang H, Barrios CH, Saji S, Jung KH, Hegg R, Koehler A, Sohn J, Iwata H, Telli ML, Ferrario C, Punie K, Penault-Llorca F, Patel S, Duc AN, Liste-Hermoso M, Maiya V, Molinero L, Chui SY, Harbeck N

  • Lancet. 2020 Oct 10;396(10257):1090-1100. doi: 10.1016/S0140-6736(20)31953-X. Epub 2020 Sep 20.

2020-10-19

Fig 1. Cardio‐oncology care pillars: a conceptual framework of cardio‐oncology initiatives.

Fig 1. Cardio‐oncology care pillars: a conceptual framework of cardio‐oncology initiatives.
  • Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, Lopez-Fernandez T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G

  • Eur J Heart Fail. 2020 Aug 18. doi: 10.1002/ejhf.1985.
Open Access button

2020-10-20

Fig. 1. Change in depression and anxiety.

Fig. 1. Change in depression and anxiety.
  • Hoyt MA, Nelson CJ

  • Contemp Clin Trials Commun. 2020 Sept;19:100648. doi: 10.1016/j.conctc.2020.100648.
Open Access button

2020-10-21

Figure 3: Force volume AFM of frozen-fixed sections from human liver. (a) Reference Masson’s trichrome-stained section of patient #3 (scale bar: 1 mm).

Figure 3: Force volume AFM of frozen-fixed sections from human liver. (a) Reference Masson’s trichrome-stained section of patient #3 (scale bar: 1 mm).
  • Calo A, Romin Y, Srouji R, Zambirinis CP, Fan N, Santella A, Feng E, Fujisawa S, Turkekul M, Huang S, Simpson AL, D'Angelica M, Jarnagin WR, Manova-Todorova K

  • Sci Rep. 2020 Sep 24;10(1):15664. doi: 10.1038/s41598-020-72564-9.
Open Access button

2020-10-22

Fig. 3.Study site does not capture the major sources of technical variation.

Fig. 3.Study site does not capture the major sources of technical variation.
  • Cristiano S, McKean D, Carey J, Bracci P, Brennan P, Chou M, Du M, Gallinger S, Goggins MG, Hassan MM, Hung RJ, Kurtz RC, Li D, Lu L, Neale R, Olson S, Petersen G, Rabe KG, Fu J, Risch H, Rosner GL, Ruczinski I, Klein AP, Scharpf RB

  • BMC Cancer. 2020 Sep 7;20(1):856.
Open Access button

2020-10-23

Figure 4. Transcription factor Pho7 recognizes a UAS element in the PHO mRNA promoters.

Figure 4. Transcription factor Pho7 recognizes a UAS element in the PHO mRNA promoters.
  • Shuman S

  • Nucleic Acids Res. 2020 Sep 4;48(15):8243-8254.
Open Access button

2020-10-26

Fig. 1. Schematic diagrams of the mechanistic tumor response model and estimation of EQD2model.

Fig. 1. Schematic diagrams of the mechanistic tumor response model and estimation of EQD2model.
  • Jeong J, Taasti VT, Jackson A, Deasy JO

  • Radiother Oncol. 2020 Sep 23. pii: S0167-8140(20)30802-1. doi: 10.1016/j.radonc.2020.09.027.

2020-10-28

Figure 4 Histologic features of epithelioid hemangioma (EH) of bone showing FOSB gene rearrangements.

Figure 4 Histologic features of epithelioid hemangioma (EH) of bone showing FOSB gene rearrangements.
  • Tsuda Y, Suurmeijer AJH, Sung YS, Zhang L, Healey JH, Antonescu CR

  • Genes Chromosomes Cancer. 2020 Oct 9. doi: 10.1002/gcc.22898.

2020-10-29

Fig. 2. Example of CT usage during a Y90 procedure.

Fig. 2. Example of CT usage during a Y90 procedure.
  • Erinjeri JP, Doustaly R, Avignon G, Bendet A, Petre EN, Ziv E, Yarmohammadi H, Solomon SB

  • BMC Med Imaging. 2020 Oct 15;20(1):114.
Open Access button

2020-10-30

Visual Abstract

Visual Abstract
  • Ghione P, Faruque P, Mehta-Shah N, Seshan V, Ozkaya N, Bhaskar S, Yeung J, Spinner MA, Lunning M, Inghirami G, Moskowitz A, Galasso N, Ganesan N, van der Weyden C, Ruan J, Prince HM, Trotman J, Advani R, Dogan A, Horwitz S

  • Blood Adv. 2020 Oct 13;4(19):4640-4647. doi: 10.1182/bloodadvances.2020002396.
Open Access button

2020-11-02

FIGURE 3: Pathology from uterine biopsy. Hematoxylin-eosin–stained slide.

FIGURE 3: Pathology from uterine biopsy. Hematoxylin-eosin–stained slide.
  • Causa Andrieu PI, Das JP, Woo S, Ryan R, Akin O, Ulaner GA

  • Clin Nucl Med. 2020 Nov;45(11):873-875.

2020-11-03

Fig.1 COMIDA implementation approaches targeting predisposing and enabling factors in the behavioral model of vulnerable populations.

Fig.1 COMIDA implementation approaches targeting predisposing and enabling factors in the behavioral model of vulnerable populations.
  • Leng J, Costas-Muniz R, Pelto D, Flores J, Ramirez J, Lui F, Tonda J, Gany F

  • J Community Health. 2020 Oct 7. pii: 10.1007/s10900-020-00933-6. doi: 10.1007/s10900-020-00933-6.

2020-11-04

Fig.1. Overview about radiation-induced acute and subacute alveolar changes.

Fig.1. Overview about radiation-induced acute and subacute alveolar changes.
  • Kasmann L, Dietrich A, Staab-Weijnitz CA, Manapov F, Behr J, Rimner A, Jeremic B, Senan S, De Ruysscher D, Lauber K, Belka C

  • Radiat Oncol. 2020 Sep 10;15(1):214.
Open Access button

2020-11-05

Fig. 2. Homozygous Smpd1 deficiency abrogates, whereas heterozygous Smpd1 deficiency moderately reduces Asm activity.

Fig. 2. Homozygous Smpd1 deficiency abrogates, whereas heterozygous Smpd1 deficiency moderately reduces Asm activity.
  • Hagemann N, Mohamud Yusuf A, Martiny C, Zhang X, Kleinschnitz C, Gunzer M, Kolesnick R, Gulbins E, Hermann DM

  • Basic Res Cardiol. 2020 Oct 14;115(6):64.
Open Access button

2020-11-06

Fig. 2 Distribution of inter-tumoral mismatch repair protein immunohistochemistry discordances among Lynch syndrome patients, patients with non-Lynch syndrome colorectal cancer predisposing syndromes, and patients with sporadic or likely sporadic gastrointestinal tract cancers

Fig. 2 Distribution of inter-tumoral mismatch repair protein immunohistochemistry discordances among Lynch syndrome patients, patients with non-Lynch syndrome colorectal cancer predisposing syndromes, and patients with sporadic or likely sporadic gastrointestinal tract cancers
  • Vyas M, Firat C, Hechtman JF, Weiser MR, Yaeger R, Vanderbilt C, Benhamida JK, Keshinro A, Zhang L, Ntiamoah P, Gonzalez M, Andrade R, El Dika I, Markowitz AJ, Smith JJ, Garcia-Aguilar J, Vakiani E, Klimstra DS, Stadler ZK, Shia J

  • Fam Cancer. 2020 Oct 9. pii: 10.1007/s10689-020-00210-4. doi: 10.1007/s10689-020-00210-4.

2020-11-09

Fig 2. The capture of all head and neck subsites, across all domains, independent of the primary treatment modality was accomplished using a system based on the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD‐10) codes.

Fig 2. The capture of all head and neck subsites, across all domains, independent of the primary treatment modality was accomplished using a system based on the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD‐10) codes.
  • Strachna O, Cohen MA, Allison MM, Pfister DG, Lee NY, Wong RJ, McBride SM, Mohammed RR, Kemeny E, Polubriaginof FCG, Kassa A, Hannon M, Cracchiolo JR

  • Cancer. 2020 Oct 27.

2020-11-10

Fig 1. The structures of the Fred Hutchinson Cancer Research Center (FHCRC) model and the Erasmus University Medical Center-MIcrosimulation SCreening ANalysis (Erasmus-MISCAN) model. PSA = prostate-specific antigen.

Fig 1. The structures of the Fred Hutchinson Cancer Research Center (FHCRC) model and the Erasmus University Medical Center-MIcrosimulation SCreening ANalysis (Erasmus-MISCAN) model. PSA = prostate-specific antigen.
  • Heijnsdijk EAM, Gulati R, Tsodikov A, Lange JM, Mariotto AB, Vickers AJ, Carlsson SV, Etzioni R

  • J Natl Cancer Inst. 2020 Oct 1;112(10):1013-1020.
Open Access button

2020-11-11

Fig 1. Mechanism of action figure

Fig 1. Mechanism of action figure
  • Laskin J, Liu SV, Tolba K, Heining C, Schlenk RF, Cheema P, Cadranel J, Jones MR, Drilon A, Cseh A, Gyorffy S, Solca F, Duruisseaux M

  • Ann Oncol. 2020 Sep 9:S0923-7534(20)42427-5.
Open Access button

2020-11-12

Fig. 4. IDH2 protein sequence in the proximity of codon R172 is remarkably similar to the IDH1 protein sequence around codon R132.

Fig. 4. IDH2 protein sequence in the proximity of codon R172 is remarkably similar to the IDH1 protein sequence around codon R132.
  • Dogan S, Frosina D, Geronimo JA, Hernandez E, Mohanty A, Bale T, Hechtman JF, Arcila ME, Hameed MR, Jungbluth AA

  • Hum Pathol. 2020 Oct 2;106:45-53. doi: 10.1016/j.humpath.2020.09.013.

2020-11-13

Fig 1. Blockage of TGF-β signalling in CD4+ T cells suppresses tumour development independently of CD8+ T cells.

Fig 1. Blockage of TGF-β signalling in CD4+ T cells suppresses tumour development independently of CD8+ T cells.
  • Liu M, Kuo F, Capistrano KJ, Kang D, Nixon BG, Shi W, Chou C, Do MH, Stamatiades EG, Gao S, Li S, Chen Y, Hsieh JJ, Hakimi AA, Taniuchi I, Chan TA, Li MO

  • Nature. 2020 Nov;587(7832):115-120.

2020-11-16

Fig. 4. Unsupervised clustering based on the delta values of the paired samples.

Fig. 4. Unsupervised clustering based on the delta values of the paired samples.
  • Garrido-Castro AC, Saura C, Barroso-Sousa R, Guo H, Ciruelos E, Bermejo B, Gavila J, Serra V, Prat A, Pare L, Celiz P, Villagrasa P, Li Y, Savoie J, Xu Z, Arteaga CL, Krop IE, Solit DB, Mills GB, Cantley LC, Winer EP, Lin NU, Rodon J

  • Breast Cancer Res. 2020 Nov 2;22(1):120. doi: 10.1186/s13058-020-01354-y.
Open Access button

2020-11-17

Graphical Abstract

Graphical Abstract
  • Lee C, Lamech L, Johns E, Overholtzer M

  • Dev Cell. 2020 Nov 9;55(3):289-297.e4. doi: 10.1016/j.devcel.2020.08.008. Epub 2020 Sep 10.

2020-11-18

Fig 5. Lethality of asp1-(W386-Stop) and asp1-(W493-Stop) is suppressed by CPF and Rhn1 mutations. Serial 5-fold dilutions of the indicated strains were spot tested for growth at the indicated temperatures.

Fig 5. Lethality of asp1-(W386-Stop) and asp1-(W493-Stop) is suppressed by CPF and Rhn1 mutations. Serial 5-fold dilutions of the indicated strains were spot tested for growth at the indicated temperatures.
  • Garg A, Shuman S, Schwer B

  • Nucleic Acids Res. 2020 Nov 4;48(19):10739-10752. doi: 10.1093/nar/gkaa776.
Open Access button

2020-11-19

Fig 5. Lineage-Specific Dynamics of ERK Activity in ICM Cells.

Fig 5. Lineage-Specific Dynamics of ERK Activity in ICM Cells.
  • Simon CS, Rahman S, Raina D, Schroter C, Hadjantonakis AK

  • Dev Cell. 2020 Nov 9;55(3):341-353.e5. doi: 10.1016/j.devcel.2020.09.030. Epub 2020 Oct 21.

2020-11-20

Fig 1. Blocking PD-1 and PD-L1 Interaction in the Tumor-Draining Lymph Node (TDLN) Confers Anti-tumor Effects

Fig 1. Blocking PD-1 and PD-L1 Interaction in the Tumor-Draining Lymph Node (TDLN) Confers Anti-tumor Effects
  • Brown CC, Wolchok JD

  • Cancer Cell. 2020 Nov 9;38(5):615-617. doi: 10.1016/j.ccell.2020.10.017.

2020-11-23

Fig 4. RNA exosome-associated proteins in human disease.

Fig 4. RNA exosome-associated proteins in human disease.
  • Weick EM, Lima CD

  • Curr Opin Struct Biol. 2020 Nov 1;67:86-94. doi: 10.1016/j.sbi.2020.09.010.
Open Access button

2020-11-24

Figure S1. ST2 expression on T cells promotes antiviral T cell response against LCMV.

Figure S1. ST2 expression on T cells promotes antiviral T cell response against LCMV.
  • Hemmers S, Schizas M, Rudensky AY

  • J Exp Med. 2021 Feb 1;218(2). pii: 211487. doi: 10.1084/jem.20201234.

2020-11-25

Fig 1. A 21-year-old man presented with a 4-month history of painless swelling in the left upper limb.

Fig 1. A 21-year-old man presented with a 4-month history of painless swelling in the left upper limb.
  • Das JP, Riedl CC, Ulaner GA

  • Clin Nucl Med. 2020 Dec;45(12):989-991. doi: 10.1097/RLU.0000000000003299.

2020-11-27

Figure 3 Comparison of breast neuroendocrine tumours (NETs) to oestrogen receptor-positive/HER2-negative breast cancer and NETs of other organ systems.

Figure 3 Comparison of breast neuroendocrine tumours (NETs) to oestrogen receptor-positive/HER2-negative breast cancer and NETs of other organ systems.
  • Pareja F, Vahdatinia M, Marchio C, Lee SSK, Da Cruz Paula A, Derakhshan F, da Silva EM, Selenica P, Dopeso H, Chandarlapaty S, Wen HY, Vincent-Salomon A, Brogi E, Weigelt B, Reis-Filho JS

  • J Clin Pathol. 2020 Nov 4. pii: jclinpath-2020-207052. doi: 10.1136/jclinpath-2020-207052.

2020-11-30

Fig. 1. Program Director Response to Likert Scale Questions.

Fig. 1. Program Director Response to Likert Scale Questions.
  • Hill MV, Ross EA, Crawford D, Lai L, Turaga K, Grubbs EG, Mullen J, Dineen S, D'Angelica M, Reddy S, Farma JM

  • Am J Surg. 2020 Nov 9. pii: S0002-9610(20)30730-3. doi: 10.1016/j.amjsurg.2020.11.007.

2020-12-01

Visual Abstract.

Visual Abstract.
  • van der Ploeg K, Le Luduec JB, Stevenson PA, Park S, Gooley TA, Petersdorf EW, Shaffer BC, Hsu KC

  • Blood Adv. 2020 Oct 13;4(19):4955-4964.
Open Access button

2020-12-02

Graphical Abstract.

Graphical Abstract.
  • Baron M, Tagore M, Hunter MV, Kim IS, Moncada R, Yan Y, Campbell NR, White RM, Yanai I

  • Cell Syst. 2020 Nov 18;11(5):536-546.e7. doi: 10.1016/j.cels.2020.08.018. Epub 2020 Sep 9.

2020-12-03

Figure 5. TEM images of (a) BT@OA, (b) BT@SiO2, (c) BT@SiO2–NH2, and (d) BT@SiO2–PEG.

Figure 5. TEM images of (a) BT@OA, (b) BT@SiO2, (c) BT@SiO2–NH2, and (d) BT@SiO2–PEG.
  • Huang RH, Sobol NB, Younes A, Mamun T, Lewis JS, Ulijn RV, O'Brien S

  • ACS Appl Mater Interfaces. 2020 Nov 18;12(46):51135-51147.

2020-12-04

Fig 3. Proportion of patients free of progression or death over time for subgroup analysis–based Kaplan-Meier estimates

Fig 3. Proportion of patients free of progression or death over time for subgroup analysis–based Kaplan-Meier estimates
  • DiSilvestro P, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian CA, Bradley WH, Mathews CA, Liu J, Lowe ES, Bloomfield R, Moore KN

  • J Clin Oncol. 2020 Oct 20;38(30):3528-3537.

2020-12-07

Figure 1. Small Molecule Inhibitors of ENPP1 Hydrolysis of 2′,3′-cGAMP.

Figure 1. Small Molecule Inhibitors of ENPP1 Hydrolysis of 2′,3′-cGAMP.
  • Cogan D, Bakhoum SF

  • Cell Chem Biol. 2020 Nov 19;27(11):1327-1328.

2020-12-08

Graphical Abstract

Graphical Abstract
  • Yewdell WT, Kim Y, Chowdhury P, Lau CM, Smolkin RM, Belcheva KT, Fernandez KC, Cols M, Yen WF, Vaidyanathan B, Angeletti D, McDermott AB, Yewdell JW, Sun JC, Chaudhuri J

  • Immunity. 2020 Nov 17;53(5):952-970.e11. doi: 10.1016/j.immuni.2020.10.003. Epub 2020 Oct 23.

2020-12-09

Fig. 1. Primary dermal melanoma, histologic features.

Fig. 1. Primary dermal melanoma, histologic features.
  • Shaigany S, Tessier-Cloutier B, Busam KJ, Horst BA

  • Hum Pathol. 2020 Sep 15;106:32-38. doi: 10.1016/j.humpath.2020.09.002.

2020-12-10

Fig. 6. Microvascular changes consistent with the sequelae of complement-mediated vascular injury localized within the fat.

Fig. 6. Microvascular changes consistent with the sequelae of complement-mediated vascular injury localized within the fat.
  • Magro CM, Mulvey JJ, Laurence J, Seshan S, Crowson AN, Dannenberg AJ, Salvatore S, Harp J, Nuovo GJ

  • Hum Pathol. 2020 Oct 12;106:106-116.
Open Access button

2020-12-11

Fig 2. 4T-Trap effectively represses TGF-β signalling in lymph node CD4+ T cells.

Fig 2. 4T-Trap effectively represses TGF-β signalling in lymph node CD4+ T cells.
  • Li S, Liu M, Do MH, Chou C, Stamatiades EG, Nixon BG, Shi W, Zhang X, Li P, Gao S, Capistrano KJ, Xu H, Cheung NV, Li MO

  • Nature. 2020 Nov;587(7832):121-125.

2020-12-14

Fig 1.  Immune reconstitution and microbiome dynamics after HCT.

Fig 1. Immune reconstitution and microbiome dynamics after HCT.
  • Schluter J, Peled JU, Taylor BP, Markey KA, Smith M, Taur Y, Niehus R, Staffas A, Dai A, Fontana E, Amoretti LA, Wright RJ, Morjaria S, Fenelus M, Pessin MS, Chao NJ, Lew M, Bohannon L, Bush A, Sung AD, Hohl TM, Perales MA, van den Brink MRM, Xavier JB

  • Nature. 2020 Dec;588(7837):303-307

2020-12-15

FIGURE 1. New trick for old dog. (A) Destruction of tumor cells with targeted radioactive isotopes is important in standard-of-care oncology.

FIGURE 1. New trick for old dog. (A) Destruction of tumor cells with targeted radioactive isotopes is important in standard-of-care oncology.
  • Pillarsetty N, Carter LM, Lewis JS, Reiner T

  • J Nucl Med. 2020 Dec;61(12):1720-1723. doi: 10.2967/jnumed.120.249748. Epub 2020 Jul 17.
Open Access button

2020-12-16

Fig 1. Newcastle disease virus (NDV) activates innate and adaptive anti-tumor immune responses.

Fig 1. Newcastle disease virus (NDV) activates innate and adaptive anti-tumor immune responses.
  • Burman B, Pesci G, Zamarin D

  • Cancers (Basel). 2020 Nov 28;12(12):E3552.
Open Access button

2020-12-17

FIGURE 1. Receptor tyrosine kinase (RTK) pathway containing RAS and BRAF.

FIGURE 1. Receptor tyrosine kinase (RTK) pathway containing RAS and BRAF.
  • Pratt EC, Isaac E, Stater EP, Yang G, Ouerfelli O, Pillarsetty N, Grimm J

  • J Nucl Med. 2020 Dec;61(12):1845-1850. doi: 10.2967/jnumed.120.241901. Epub 2020 May 22.
Open Access button

2020-12-18

Regulation of tricellular adhesion by tension requires Canoe and the Abl tyrosine kinase.

Regulation of tricellular adhesion by tension requires Canoe and the Abl tyrosine kinase.
  • Yu HH, Zallen JA

  • Science. 2020 Nov 27;370(6520):eaba5528

2020-12-21

Figure 3. MEK1/2(i) and HSP90(i) synergize to suppress the PI3K/AKT/mTOR and MAPK signaling pathways.

Figure 3. MEK1/2(i) and HSP90(i) synergize to suppress the PI3K/AKT/mTOR and MAPK signaling pathways.
  • Grbovic-Huezo O, Pitter KL, Lecomte N, Saglimbeni J, Askan G, Holm M, Melchor JP, Chandwani R, Joshi S, Haglund C, Iacobuzio-Donahue CA, Chiosis G, Tammela T, Leach SD

  • Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30670-30678. doi: 10.1073/pnas.1920240117. Epub 2020 Nov 16.
Open Access button

2020-12-22

Fig 1. The largest connected network in the list of 144 genes. The line colors indicate the activation (green), inhibition (red), and unspecified (gray) effects.

Fig 1. The largest connected network in the list of 144 genes. The line colors indicate the activation (green), inhibition (red), and unspecified (gray) effects.
  • Oh JH, Tannenbaum A, Deasy JO

  • BMC Med Genomics. 2020 Dec 11;13(1):186. doi: 10.1186/s12920-020-00839-1.
Open Access button

2020-12-23

Visual Abstract.

Visual Abstract.
  • Roeker LE, Mato AR

  • Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):10-17. doi: 10.1182/hematology.2020000168.
Open Access button

2020-12-24

Fig 4. Isabl applications enable systematic processing of experimental data.

Fig 4. Isabl applications enable systematic processing of experimental data.
  • Medina-Martínez JS, Arango-Ossa JE, Levine MF, Zhou Y, Gundem G, Kung AL, Papaemmanuil E

  • BMC Bioinformatics. 2020 Nov 30;21(1):549.
Open Access button

2020-12-28

Graphical Abstract.

Graphical Abstract.
  • Roudko V, Bozkus CC, Orfanelli T, McClain CB, Carr C, O'Donnell T, Chakraborty L, Samstein R, Huang KL, Blank SV, Greenbaum B, Bhardwaj N

  • Cell. 2020 Dec 10;183(6):1634-1649.e17. doi: 10.1016/j.cell.2020.11.004. Epub 2020 Nov 30.

2020-12-29

Graphical Abstract

Graphical Abstract
  • Wiedemann GM, Grassmann S, Lau CM, Rapp M, Villarino AV, Friedrich C, Gasteiger G, O'Shea JJ, Sun JC

  • Cell Rep. 2020 Dec 15;33(11):108498. doi: 10.1016/j.celrep.2020.108498.
Open Access button

2020-12-30

FIGURE 1. A 54-year-old woman (no. 5) with secondary CNSL adjacent to the left interventricular foramen (arrows).

FIGURE 1. A 54-year-old woman (no. 5) with secondary CNSL adjacent to the left interventricular foramen (arrows).
  • Starzer AM, Berghoff AS, Traub-Weidinger T, Haug AR, Widhalm G, Hacker M, Rausch I, Preusser M, Mayerhoefer ME

  • Clin Nucl Med. 2021 Jan;46(1):16-20. doi: 10.1097/RLU.0000000000003404.

2020-12-31

Fig. 3. A) The scatter plot of Image AGD versus CBT for all lesions demonstrates the large variability in CBT; There is a moderate and positive correlation in the Image AGD regression model (DBT, r2 = 0.4) confirming that dose increases with CBT.

Fig. 3. A) The scatter plot of Image AGD versus CBT for all lesions demonstrates the large variability in CBT; There is a moderate and positive correlation in the Image AGD regression model (DBT, r2 = 0.4) confirming that dose increases with CBT.
  • Amir T, Zuckerman SP, Barufaldi B, Maidment AD, Conant EF

  • Eur J Radiol. 2020 Nov 11;134:109407. doi: 10.1016/j.ejrad.2020.109407.